March 20, 2014 |
GLASSBORO Rowan University announced Tuesday that it had entered an agreement with Lockheed Martin to have the company collaborate with the university's students and faculty on research and development of radar technology. The move builds on a project begun last fall and, Rowan administrators said, is a new model for universities working with industry. The school has made high-profile pledges to expand, especially its research enterprise, with the engineering school seen as a core part of that mission.
March 14, 2014 |
HARRISBURG Auditor General Eugene DePasquale announced Wednesday that he was undertaking an audit of the state health department's handling of nearly $800 million in research funding provided by the national tobacco settlement. "These funds are intended to fuel health-care research that could help people live longer, healthier, and more rewarding lives," DePasquale said. "We have to make sure these research programs are meeting expectations so that nothing jeopardizes their vital mission or erodes public confidence.
March 13, 2014 |
GLASSBORO Months after it became the second state-recognized public research university in New Jersey, Rowan University on Tuesday announced a new effort to connect faculty and student research initiatives with the dollars needed to kick-start them. The Rowan University Foundation, a fund-raising branch of the university, has allocated $5 million to the new program, called the Rowan Venture Fund. University officials said that the new fund was unique in the region and that it would help research ideas get started at "their earliest stages," potentially breeding job growth and economic activity.
March 9, 2014 |
With surgery and chemotherapy, Roberta Bash, 67, of Downingtown beat advanced-stage ovarian cancer in 2010. Then, it came back. "Cancer can go dormant, and I didn't know that," she said. The second time, Bash wanted to explore all her options - including an experimental treatment at Penn Medicine that manipulates a patient's tumor cells to trigger an immune response. So, during her surgery last March, instead of allowing her tumor to be tossed out or donated for research, she saved it. The company StoreMyTumor, which markets itself as a concierge service for tumors, negotiated the tissue's harvest, processing, and cryopreservation.
March 7, 2014 |
University of Pennsylvania researchers have snipped out a single gene in patients' immune cells to make them partly resistant to infection with HIV, the virus that causes AIDS. The study, in this week's New England Journal of Medicine, bolsters hope for controlling HIV without daily antiviral drugs - a so-called functional cure. But even more important, as the first paper to report the modification of an exact spot in human DNA, it marks the arrival of the age of gene editing.
March 5, 2014 |
Wind turbines have been lauded as carbon-free energy sources, and denounced as whirring monsters that kill birds, bats, and scenic views. The twain have yet to meet. But what if wind energy could do more than just crank out electricity? What if it could blow away Mother Nature with a massive offshore array of turbines powerful enough to blunt the force of hurricanes? Researchers from the University of Delaware and Stanford University have concluded it is possible. Their computer model showed that a large wind farm off the East Coast could have have reduced the wind speed of Hurricane Sandy about 80 m.p.h., and lessened the storm surge - the flooding that ruined so many homes and businesses - up to 21 percent.
March 2, 2014 |
HARRISBURG - Last fall, the director of the University of Pennsylvania's Abramson Cancer Center briefed the legislative cancer caucus on the center's groundbreaking research on a variety of potentially deadly forms of the disease. In one case detailed by Chi Dang, doctors with Penn and Children's Hospital of Philadelphia used a novel cell-engineering treatment on a young leukemia patient as part of a clinical trial involving acute forms of leukemia. That was two years ago. The little girl remains cancer-free.
February 28, 2014 |
Personalized medicine is all the rage in cancer treatment, as doctors increasingly tailor medicines to specific mutations in patients' tumors. Now, the approach is making its way into addiction treatment. A new study from the University of Pennsylvania found that heavy drinkers significantly reduced their drinking when they took the anticonvulsant drug topiramate - but only if they had a specific genetic profile. Henry R. Kranzler, director of Penn's Center for Studies of Addiction and the study's lead author, said researchers also have found that genes affect response to two other drugs being tested in alcoholics: naltrexone and ondansetron, an antinausea drug.
February 19, 2014 |
Slavica Matacic, 80, of Haverford, a pioneering researcher and professor of biology at Haverford College who worked to widen the study of sciences among women and minorities, died of pneumonia Wednesday, Feb. 5, at Bryn Mawr Hospital. When Dr. Matacic arrived at Haverford in 1964, the faculty was predominantly male. Over the next three and a half decades, until retiring in 1999, she worked to promote the success of women, minorities, and students who were the first in their families to attend college.
February 5, 2014 |
Greek and Roman historians were fond of depicting northern Europeans as beer-swilling barbarians, incapable of appreciating the fruits of sun-splashed Mediterranean vineyards. Writing in the late first century B.C., Dionysius of Halicarnassus sniffed that northerners were known to drink a "foul-smelling liquor made from barley rotted in water. " Time to give the barbarians some credit, says University of Pennsylvania archaeologist Patrick E. McGovern. Chemical analysis of residues from ancient drinking vessels and strainers, found in what are now Denmark and Sweden, reveal traces of elaborate hybrid beverages made from berries, birch resin, honey, and herbs, McGovern said.